Dr Anderson on the FDA ODAC Decision Regarding Cilta-Cel in R/R Multiple Myeloma OncLive - 29 Apr 2024 Dr Anderson on the FDA ODAC Decision Regarding Cilta-Cel in R/R Multiple Myeloma ... More
Exa-Cel Eliminates Vaso-Occlusive Crises in Most Sickle Cell Patients Physician's Weekly - 26 Apr 2024 Exa-Cel Eliminates Vaso-Occlusive Crises in Most Sickle Cell Patients ... More
Lovo-cel, now Lyfgenia wins FDA approval for sickle cell disease Sickle Cell Disease News - 08 Dec 2023 Lovo-cel, now Lyfgenia wins FDA approval for sickle cell disease ... More
FDA pushes back decision date on pz-cel treatment for RDEB Epidermolysis Bullosa News - 26 Apr 2024 FDA pushes back decision date on pz-cel treatment for RDEB ... More
FDA rejects Abeona' Therapeutics' topical gene therapy pz-cel FiercePharma - 23 Apr 2024 FDA rejects Abeona' Therapeutics' topical gene therapy pz-cel ... More
Cilta-cel Produces MRD Negativity, Responses in Relapsed/Refractory Multiple Myeloma www.oncnursingnews.com/ - 26 Apr 2024 Cilta-cel Produces MRD Negativity, Responses in Relapsed/Refractory Multiple Myeloma ... More
Dr Binod Dhakal Discusses Game-Changing Cilta-Cel Approval for RRMM AJMC.com Managed Markets Network - 24 Apr 2024 Dr Binod Dhakal Discusses Game-Changing Cilta-Cel Approval for RRMM ... More
Call of Duty's upcoming Cel-Shaded skin opens new crossover possibilities in Warzone and MW3 Sportskeeda - 25 Apr 2024 Call of Duty's upcoming Cel-Shaded skin opens new crossover possibilities in Warzone and MW3 ... More
CRL issued for pz-cel as potential recessive dystrophic epidermolysis bullosa treatment Contemporary Pediatrics - 23 Apr 2024 CRL issued for pz-cel as potential recessive dystrophic epidermolysis bullosa treatment ... More
FDA Approves First CRISPR Gene Editing Treatment for Sickle Cell Disease Scientific American - 08 Dec 2023 FDA Approves First CRISPR Gene Editing Treatment for Sickle Cell Disease ... More
CEL-SCI Appoints Mario Gobbo to Its Board of Directors Business Wire - 23 Apr 2024 CEL-SCI Appoints Mario Gobbo to Its Board of Directors ... More
Afami-cel provides a novel treatment option for rare sarcoma subtypes Nature.com - 18 Apr 2024 Afami-cel provides a novel treatment option for rare sarcoma subtypes ... More
Statutory Profit Doesn't Reflect How Good CEL's (TSE:5078) Earnings Are Simply Wall St - 19 Apr 2024 Statutory Profit Doesn't Reflect How Good CEL's (TSE:5078) Earnings Are ... More
The Prospect of Pz-cel in RDEB Treatment, with Peter Marinkovich, MD MD Magazine - 06 Mar 2024 The Prospect of Pz-cel in RDEB Treatment, with Peter Marinkovich, MD ... More
I received the new gene-editing drug for sickle-cell disease. It changed my life. MIT Technology Review - 04 Dec 2023 I received the new gene-editing drug for sickle-cell disease. It changed my life. ... More
Abeona Therapeutics Provides Regulatory Update on Pz-cel GlobeNewswire - 22 Apr 2024 Abeona Therapeutics Provides Regulatory Update on Pz-cel ... More
FDA meet on exa-cel for SCD complete ahead of approval decision Sickle Cell Disease News - 02 Nov 2023 FDA meet on exa-cel for SCD complete ahead of approval decision ... More
CEL-SCI's LEAPS Vaccine Offers Promising New Paradigm to Treat Rheumatoid Arthritis: Published in Frontiers in ... Business Wire - 19 Mar 2024 CEL-SCI's LEAPS Vaccine Offers Promising New Paradigm to Treat Rheumatoid Arthritis: Published in Frontiers in ... ... More
Real-world impact of bridging therapy on outcomes of ide-cel for myeloma in the U.S. Myeloma Immunotherapy ... Nature.com - 12 Apr 2024 Real-world impact of bridging therapy on outcomes of ide-cel for myeloma in the U.S. Myeloma Immunotherapy ... ... More